Drug Shortage Report for INTEGRILIN

Last updated on 2017-08-14 History
Report ID 16762
Drug Identification Number 02240351
Brand name INTEGRILIN
Common or Proper name Eptifibatide Injection
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) EPTIFIBATIDE
Strength(s) 0.75MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 100ML VIAL
ATC code B01AC
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2017-08-21
Actual start date
Estimated end date 2017-08-31
Actual end date 2017-08-14
Shortage status Avoided shortage
Updated date 2017-08-14
Company comments
Health Canada comments
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2017-08-14 French Compare
v7 2017-08-14 English Compare
v6 2017-08-01 French Compare
v5 2017-08-01 English Compare
v4 2017-07-31 French Compare
v3 2017-07-31 English Compare
v2 2017-07-24 French Compare
v1 2017-07-24 English Compare